NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / Technology News / COVID-19 vaccine: India to produce 300 million Sputnik V doses
    COVID-19 vaccine: India to produce 300 million Sputnik V doses
    1/5
    Technology 2 min read

    COVID-19 vaccine: India to produce 300 million Sputnik V doses

    By Siddhant Pandey
    Dec 18, 2020
    07:04 pm
    COVID-19 vaccine: India to produce 300 million Sputnik V doses

    India will reportedly produce around 300 million doses of the Russian COVID-19 vaccine called Sputnik V. The figure is nearly three times the previously known number of doses that India was aiming to produce. The Russian Direct Investment Fund (RDIF) and the Gamaleya National Center of Epidemiology and Microbiology have jointly developed the vaccine, which has been found at least 91.4% effective.

    2/5

    Russia has agreements with four Indian vaccine manufacturers: RDIF head

    "In India, we have agreements with four large manufacturers," RDIF head Kirill Dmitriev told Rossiya 24 TV, according to news agency TASS. "India will produce about 300 million doses or more of the vaccine for us next year." Russia is already testing the first samples of Sputnik V produced in India, the Russian embassy in New Delhi wrote on Twitter on Friday.

    3/5

    Hetero Biopharma to produce over 100 doses

    Hyderabad-based Hetero Biopharma has announced a deal with the RDIF to produce over 100 million doses of Sputnik V. It remains unclear which other Indian companies will be producing the Russian vaccine. However, Dr. Reddy's Laboratories Ltd, which has been conducting clinical trials for Sputnik V in India, has also struck a deal to distribute the COVID-19 vaccine.

    4/5

    Three vaccines under consideration for emergency approval in India

    The Indian government has been reviewing the emergency approval applications for three potential vaccines: Oxford University and AstraZeneca's vaccine, labeled 'Covishield' in India; Bharat Biotech's indigenously-developed COVAXIN, and Pfizer-BioNTech's BNT162b2. The Health Ministry has said that emergency approval is expected in the coming weeks. Notably, Pfizer's vaccine has been rolled out in several countries including the United Kingdom and the United States.

    5/5

    How bad is the outbreak in India?

    According to the Health Ministry, as of Friday morning, India reported 99,79,447 COVID-19 cases, with 22,890 fresh infections in the past 24 hours. India is the world's second worst-hit country in the outbreak after the US. The total cases include 3,13,831 active infections and 95,20,827 recoveries. The death toll has risen to 1,44,789 with 338 more fatalities in the past 24 hours.

    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    India
    Russia News
    Bharat Biotech
    BioNTech
    Sputnik V

    India

    Gold worth Rs. 1.10 crore goes missing from Customs custody Narendra Modi
    Jeep Compass (facelift) to be launched next month; bookings open Jeep Compass
    States to undertake fire safety audits of COVID-19 hospitals: SC Supreme Court Of India
    Australia vs India, 1st Test: Day 2 Session 1 report Virat Kohli

    Russia News

    India rejects large scale trial of Russia's COVID-19 vaccine Central Drugs Standard Control Organization (CDSCO)
    One in seven volunteers for Sputnik V report side effects Vaccine
    Dr. Reddy's bringing coronavirus vaccine to India by 2020-end NITI Aayog
    Honor 30i, with Kirin 710F chipset and triple cameras, launched Kirin

    Bharat Biotech

    India's neighbors train experts for clinical trials of COVID-19 vaccine Sri Lanka
    How Delhi plans to carry out COVID-19 vaccinations All India Institute Of Medical Sciences (AIIMS)
    Here's how the government is planning to conduct COVID-19 vaccinations Times of India
    No emergency approval for SII, Bharat Biotech's vaccine candidates yet Serum Institute of India

    BioNTech

    US angling to secure more of Pfizer's coronavirus vaccine Donald Trump
    Talk show host Ellen DeGeneres has tested positive for COVID-19 Instagram
    Pfizer vaccine: UK issues allergy warning after two adverse reactions Pfizer
    COVID-19 vaccine: 90-year-old woman receives first Pfizer shot in UK Pfizer

    Sputnik V

    India to produce 100 million Sputnik V doses starting 2021 India
    Russia's Sputnik V at least 91% effective, early data suggests Oxford University
    Russia's Sputnik V to start human trials in India soon NITI Aayog
    Sputnik V Phase-II trials to have 100 volunteers: Dr. Reddy's Vaccine
    Next News Article

    Love Technology News?

    Subscribe to stay updated.

    Science Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023